A detailed history of Aqr Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 120,743 shares of AMGN stock, worth $34.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
120,743
Previous 73,124 65.12%
Holding current value
$34.8 Million
Previous $22.8 Million 70.28%
% of portfolio
0.05%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $14.7 Million - $16.1 Million
47,619 Added 65.12%
120,743 $38.9 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $48.5 Million - $58.9 Million
-184,448 Reduced 71.61%
73,124 $22.8 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $184 Million - $222 Million
-684,325 Reduced 72.65%
257,572 $73.2 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $36.9 Million - $41.6 Million
144,153 Added 18.07%
941,897 $271 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $19.2 Million - $23.8 Million
87,760 Added 12.36%
797,744 $214 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $13.7 Million - $16.1 Million
63,736 Added 9.86%
709,984 $158 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $8.97 Million - $10.9 Million
39,731 Added 6.55%
646,248 $156 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $4.35 Million - $5.53 Million
-18,991 Reduced 3.04%
606,517 $159 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $13 Million - $14.7 Million
58,049 Added 10.23%
625,508 $141 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $38.1 Million - $42.4 Million
-165,312 Reduced 22.56%
567,459 $137 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $33.8 Million - $37.4 Million
-154,224 Reduced 17.39%
732,771 $177 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $59.1 Million - $67.7 Million
-297,260 Reduced 25.1%
886,995 $200 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $3.85 Million - $4.51 Million
-18,128 Reduced 1.51%
1,184,255 $252 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $17 Million - $18.8 Million
72,616 Added 6.43%
1,202,383 $291 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $15.6 Million - $18.1 Million
70,114 Added 6.62%
1,129,767 $281 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $30.1 Million - $35.8 Million
-139,105 Reduced 11.6%
1,059,653 $240 Million
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $42.8 Million - $47.6 Million
-182,304 Reduced 13.2%
1,198,758 $300 Million
Q2 2020

Aug 17, 2020

SELL
$197.81 - $242.74 $72.7 Million - $89.2 Million
-367,555 Reduced 21.02%
1,381,062 $321 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $67.2 Million - $89.1 Million
368,603 Added 26.71%
1,748,617 $351 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $34.5 Million - $44.4 Million
182,509 Added 15.24%
1,380,014 $331 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $86.5 Million - $104 Million
-496,897 Reduced 29.33%
1,197,505 $232 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $178 Million - $209 Million
-1,068,591 Reduced 38.68%
1,694,402 $312 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $58.3 Million - $65.7 Million
-322,075 Reduced 10.44%
2,762,993 $525 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $31.7 Million - $37 Million
177,493 Added 6.1%
3,085,068 $601 Million
Q3 2018

Nov 15, 2018

BUY
$185.29 - $208.89 $143 Million - $162 Million
773,506 Added 36.25%
2,907,575 $603 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $127 Million - $143 Million
-764,378 Reduced 26.37%
2,134,069 $394 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $126 Million - $147 Million
-743,483 Reduced 20.41%
2,898,447 $494 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $121 Million - $135 Million
714,906 Added 24.42%
3,641,930 $633 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $490 Million - $559 Million
2,927,024
2,927,024 $546 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.